Follow us

Tom acts for financial sponsors, listed companies and founders on private M&A and other negotiated transactions.

Tom advises a range of Australian and international clients on acquisitions, disposals, restructures, capital raisings, joint ventures, management equity and W&I insurance.

He is actively involved in managing some of the firm’s key private equity client relationships and has previously undertaken a secondment as legal counsel at Archer Capital, a leading Australian private equity firm.

Prior to joining the firm, Tom worked for a number of years at the Macquarie Group.

Background

Tom holds a Bachelor of Commerce (Accounting and Industrial Relations) from the University of Sydney and a Bachelor of Laws (First Class Honours) from the University of Technology Sydney.

Experience & expertise

Selected matters

  • Mercury Capital on its acquisition of Fyfe
  • Mercury Capital on its acquisition of JMC Academy
  • Mercury Capital on the sale of Australian Animal Hospitals to Vet Partners
  • Mercury Capital on the sale of MessageMedia to Sinch
  • Archer Capital on the sale of Brownes Dairy to Shanghai Ground Food Tech
  • Archer Capital on the sale of Craveable Brands to PAG Asia Capital
  • Archer Capital on the sale of Autopact to Optimus Group
  • Pacific Equity Partners and Blum Capital on its refinance and subsequent sale of Xtralis to Honeywell
  • Pacific Equity Partners on its bid for Lion Dairy and Drinks
  • Potentia Capital on its acquisition of Education Horizons Group by way of unlisted takeover bid
  • Adamantem Capital (with Liverpool Partners) on its acquisition of Zenitas Healthcare by way of scheme of arrangement
  • American Securities on its acquisition of Hexion
  • Apollo Global Management on its acquisition of Ingenico
  • Catalyst on the dual track sale / IPO of Dusk
  • EQT on its proposed acquisition of IRESS via scheme of arrangement
  • Fidelio Capital and Vimian on its acquisition of Bova Compounding
  • Roc Partners on its acquisition of Story House Early Learning
  • The Growth Fund on its investment in M&J Chickens, Black Mount Spring Water, Quantum Radiology, My Pet Warehouse, Askin Performance Panels, Fitness Passport, AFS Logistics and Soar Aviation
  • The Growth Fund on portfolio company matters including for Ekera Dental, Obex Medical, Best Friends Pets, CompassCorp, GoGet, Royans and PlanIt
  • GenesisCare on its investment from KKR
  • GenesisCare on its acquisition of CardioNexus and Burwood Cardiology
  • GenesisCare on the sale of Advara HeartCare to Adamantem Capital
  • CIMIC on the sale of Leighton and Thiess Services and the creation of the Ventia joint venture with Apollo Global Management
  • Ventia (and its shareholders CIMIC and Apollo) on its acquisition of Broadspectrum from Ferrovial
  • Ventia (and its shareholders CIMIC and Apollo) on its initial public offering and listing on the ASX
  • Ventia on the sale of APP Corporation to Five V Capital
  • Ventia on its acquisition of Kordia Solutions
  • Ventia on the sale of its interest in the MTC Broadspectrum joint venture
  • Ventia on its EarthSure joint venture with Veolia
  • Link Group on the proposed sale of its corporate markets and banking and credit management businesses to Dye & Durham
  • GreenMount Advisory on its investment from Ngāi Tahu Holdings
  • GUD Holdings on its acquisition of ACAD from AMA Group
  • OPW on its acquisition of Liquip
  • Spark Infrastructure on its acquisition of Bomen Solar Farm from Renew Estate
  • Ennismore on its joint venture with Accor
  • ANZ and CBA as financiers for the acquisition by Stockland and Supalai of 12 master-planned communities from Lendlease
  • Permodalan Nasional Berhad on its investment in the Elanor Healthcare Real Estate Fund
  • City Developments Limited on its acquisition of Sofitel Brisbane from Brookfield
  • ACE Specialist HSC Tuition on its sale to Matrix Education (a portfolio company of Mercury Capital)
  • Upper Hunter Hydro on management equity arrangements
  • Ansarada on its Series A capital raise
  • SafetyCulture on its Series B capital raise
  • SoftBank on portfolio company matters
  • InfraRed Capital Partners on proposed investments